Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Blue Yonder that has a suit against the company is pointing to only $20 million in lost sales. With an annual revenue of $200M, it is not particularly material. There is not too much concern with this news. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The company was able to grow pre-pandemic and 5i sees no reason why it cannot continue even after COVID. Profit-taking and sector rotation can be painful but the long term prospect remains positive. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The company was able to grow pre-pandemic and 5i sees no reason why it cannot continue even after COVID. Profit-taking and sector rotation can be painful but the long term prospect remains positive. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. A cloud-based subscription software for supply chain operation. It has a great balance sheet with high growth potential. Global growth is also a possibility. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. A cloud-based subscription software for supply chain operation. It has a great balance sheet with high growth potential. Global growth is also a possibility. Unlock Premium - Try 5i Free
Is among good Canadian tech stocks or else buy XIT ETF. KXS has been volatile, but lately has been improving. Its November move upwards was good. Stick with it, if you already own.
Shopify Shopify is a great company, but the valuation is scary. For Canadian growth, he prefers Kinaxis which has half the growth but the valuation is nowhere as high. If there's a pullback, Shopify will fall further.
Kinaxis Inc is a Canadian stock, trading under the symbol KXS-T on the Toronto Stock Exchange (KXS-CT). It is usually referred to as TSX:KXS or KXS-T
In the last year, 10 stock analysts published opinions about KXS-T. 6 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is HOLD. Read the latest stock experts' ratings for Kinaxis Inc.
Kinaxis Inc was recommended as a Top Pick by Stockchase Insights on 2020-12-28. Read the latest stock experts ratings for Kinaxis Inc.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
10 stock analysts on Stockchase covered Kinaxis Inc In the last year. It is a trending stock that is worth watching.
On 2021-03-03, Kinaxis Inc (KXS-T) stock closed at a price of $163.16.
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Blue Yonder that has a suit against the company is pointing to only $20 million in lost sales. With an annual revenue of $200M, it is not particularly material. There is not too much concern with this news. Unlock Premium - Try 5i Free